Investors

FSD is a specialty, biotech pharmaceutical R&D company that aims to deliver growth and returns to shareholders through the development over time of multiple applications of the company’s lead compound FSD201, ultra-micronized PEA.

Shareholder Information

COMPANY INFORMATION

Legal Counsel
Bennet Jones, LLP

Auditor
MNP LLP

Fiscal Year End
December 31

Jurisdiction
Ontario, Canada

Transfer Agent
Computershare Trust Corporation

CLASS A SHARES – ISSUED & OUTSTANDING

72

CLASS B SUBORDINATE VOTING SHARES

CUSIP
35954B206

ISIN
CA35954B2066

Capital Structure – Issued & Outstanding Basic
10,219,769

Capital Structure – Issued & Outstanding Fully Diluted
12,277,628

CSE Symbol:

Class B Subordinate Voting Shares

HUGE

Investor Contact Details

The FSD investor relations team responds to requests from professional members of the financial community.

[email protected]

Events & Presentations